Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PIK3CA and AKT1 mutations are independent in invasive breast cancer
    Meeting Abstract

    Moynahan, M. E.; Heguy, A.; Drobnjak, M.; Traina, T.; Howard, J.; Patil, S.; Gerald, W.; Solit, D.; Hudis, C.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Adjuvant dose-dense doxorubicin-cyclophosphamide x 4 with or without bevacizumab is safe: No evidence of short-term changes in left ventricular ejection fraction
    Meeting Abstract

    Morris, P. G.; Dickler, M.; Mcarthur, H.; Traina, T.; Godfrey, L.; Steingart, R.; Rugo, H.; Lin, N.; Moy, B.; Come, S.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Cardiac safety of adjuvant bevacizumab (B) plus dose-dense doxorubicin/cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel (nab-P) in patients with early stage breast cancer
    Meeting Abstract

    Mcarthur, H.; Rugo, H.; Nulsen, B.; Traina, T.; Patil, S.; Zhou, Q.; Steingart, R.; Dang, C.; Park, J.; Moasser, M.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Bone scintigraphy (BS) may no longer be relevant in the era of integrated PET/CT for women undergoing evaluation for suspected metastatic breast cancer (MBC)
    Meeting Abstract

    Mcarthur, H. L.; Lynch, C.; Morris, P.; Larson, S.; Grabski, K.; Howard, J.; Patil, S.; Hudis, C. A.; Dickler, M. N.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • High resolution representational oligonucleotide microarray analysis (ROMA) suggests that TOPO2 and HER2 co-amplification is uncommon in human breast cancer
    Meeting Abstract

    Mcarthur, H. L.; Tan, L. K.; Patil, S.; Wigler, M.; Hudis, C. A.; Hicks, J.; Norton, L.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • A phase I study of weekly dosing of trastuzumab-DM1 (T-DM1) in patients with advanced HER2+breast cancer
    Meeting Abstract

    Krop, I. E.; Mita, M.; Burris, H. A.; Birkner, M.; Girish, S.; Tibbitts, J.; Holden, S. N.; Lutzker, S. G.; Modi, S.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Clinical utility and future of genetic profiles for breast cancer
    Journal Article

    Hudis, C.
    Breast Cancer Research (2009)

    Fulltext@MSK | Save
  • TOPO2A and HER2 co-amplification is uncommon by high resolution representational oligonucleotide microarray analysis (ROMA) in human breast cancer
    Meeting Abstract

    Hicks, J.; Mcarthur, H.; Tan, L. K.; Patil, S.; Wigler, M.; Hudis, C.; Norton, L.
    Annals of Oncology (2009)

    Fulltext@MSK | Save
  • Topoisomerase II alpha amplification does not predict benefit from dose-intense cyclophosphamide, doxorubicin, and fluorouracil therapy in HER2-amplified early breast cancer: Results of CALGB 8541/150013
    Journal Article

    Harris, L. N.; Broadwater, G.; Abu-Khalaf, M.; Cowan, D.; Thor, A. D.; Budman, D.; Cirrincione, C. T.; Berry, D. A.; Winer, E. P.; Hudis, C. A.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Role of anthracyclines in the treatment of early breast cancer
    Journal Article

    Gianni, L.; Norton, L.; Wolmark, N.; Suter, T. M.; Bonadonna, G.; Hortobagyi, G. N.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save